314 related articles for article (PubMed ID: 28659221)
21. Drug-induced QT Interval Prolongation in the Intensive Care Unit.
Etchegoyen CV; Keller GA; Mrad S; Cheng S; Di Girolamo G
Curr Clin Pharmacol; 2017; 12(4):210-222. PubMed ID: 29473523
[TBL] [Abstract][Full Text] [Related]
22. Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium.
Vandael E; Vandenberk B; Vandenberghe J; Spriet I; Willems R; Foulon V
Int J Clin Pharm; 2016 Apr; 38(2):310-20. PubMed ID: 26749342
[TBL] [Abstract][Full Text] [Related]
23. QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors.
Spellmann I; Reinhard MA; Veverka D; Zill P; Obermeier M; Dehning S; Schennach R; Müller N; Möller HJ; Riedel M; Musil R
Eur Arch Psychiatry Clin Neurosci; 2018 Jun; 268(4):383-390. PubMed ID: 29429138
[TBL] [Abstract][Full Text] [Related]
24. Cardiac safety parameters of olanzapine: comparison with other atypical and typical antipsychotics.
Czekalla J; Kollack-Walker S; Beasley CM
J Clin Psychiatry; 2001; 62 Suppl 2():35-40. PubMed ID: 11232751
[TBL] [Abstract][Full Text] [Related]
25. QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia.
Ozeki Y; Fujii K; Kurimoto N; Yamada N; Okawa M; Aoki T; Takahashi J; Ishida N; Horie M; Kunugi H
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):401-5. PubMed ID: 20079791
[TBL] [Abstract][Full Text] [Related]
26. QTc prolongation in schizophrenia patients in Asia: clinical correlates and trends between 2004 and 2008/2009.
Xiang YT; Chiu HF; Ungvari GS; Correll CU; Lai KY; Wang CY; Si TM; Lee EH; He YL; Yang SY; Chong MY; Kua EH; Fujii S; Sim K; Yong MK; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Tan CH; Shinfuku N
Hum Psychopharmacol; 2015 Mar; 30(2):94-9. PubMed ID: 25611192
[TBL] [Abstract][Full Text] [Related]
27. [Antipsychotic pharmacotherapy for delirious syndromes - only temporary, symptom-oriented and considering QTc time].
Schwerthöffer D; Förstl H; Fatke B
MMW Fortschr Med; 2019 Jul; 161(Suppl 5):1-6. PubMed ID: 31313266
[TBL] [Abstract][Full Text] [Related]
28. Effect of antipsychotic use by patients with schizophrenia on deceleration capacity and its relation to the corrected QT interval.
Okayasu H; Shinozaki T; Takano Y; Sugawara N; Fujii K; Yasui-Furukori N; Ozeki Y; Shimoda K
Gen Hosp Psychiatry; 2023; 81():15-21. PubMed ID: 36716654
[TBL] [Abstract][Full Text] [Related]
29. Predictive factors for QTc prolongation in schizophrenic patients taking antipsychotics.
Lin CH; Chen MC; Wang SY; Lin CY
J Formos Med Assoc; 2004 Jun; 103(6):437-41. PubMed ID: 15278188
[TBL] [Abstract][Full Text] [Related]
30. QTc prolongation, torsades de pointes, and psychotropic medications.
Beach SR; Celano CM; Noseworthy PA; Januzzi JL; Huffman JC
Psychosomatics; 2013; 54(1):1-13. PubMed ID: 23295003
[TBL] [Abstract][Full Text] [Related]
31. Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study.
Watanabe J; Suzuki Y; Fukui N; Ono S; Sugai T; Tsuneyama N; Someya T
J Clin Psychopharmacol; 2012 Feb; 32(1):18-22. PubMed ID: 22198445
[TBL] [Abstract][Full Text] [Related]
32. Prolonged QTc intervals in medicated patients with schizophrenia.
Chong SA; Mythily ; Lum A; Goh HY; Chan YH
Hum Psychopharmacol; 2003 Dec; 18(8):647-9. PubMed ID: 14696025
[TBL] [Abstract][Full Text] [Related]
33. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
Othong R; Devlin JJ; Kazzi ZN
Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
[TBL] [Abstract][Full Text] [Related]
34. New Generation Antipsychotic Drugs and QTc Interval Prolongation.
Vieweg WV
Prim Care Companion J Clin Psychiatry; 2003 Oct; 5(5):205-215. PubMed ID: 15213787
[TBL] [Abstract][Full Text] [Related]
35. Sex differences in the effect of four second-generation antipsychotics on QTc interval in patients with schizophrenia.
Suzuki Y; Sugai T; Fukui N; Watanabe J; Ono S; Tsuneyama N; Saito M; Someya T
Hum Psychopharmacol; 2013 May; 28(3):215-9. PubMed ID: 23553637
[TBL] [Abstract][Full Text] [Related]
36. Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study.
Baandrup L; Gasse C; Jensen VD; Glenthoj BY; Nordentoft M; Lublin H; Fink-Jensen A; Lindhardt A; Mortensen PB
J Clin Psychiatry; 2010 Feb; 71(2):103-8. PubMed ID: 19895781
[TBL] [Abstract][Full Text] [Related]
37. Long-term treatment with antipsychotic drugs in conventional doses prolonged QTc dispersion, but did not increase ventricular tachyarrhythmias in patients with schizophrenia in the absence of cardiac disease.
Kitayama H; Kiuchi K; Nejima J; Katoh T; Takano T; Hayakawa H
Eur J Clin Pharmacol; 1999 Jun; 55(4):259-62. PubMed ID: 10424317
[TBL] [Abstract][Full Text] [Related]
38. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature.
Lawrence KR; Nasraway SA
Pharmacotherapy; 1997; 17(3):531-7. PubMed ID: 9165555
[TBL] [Abstract][Full Text] [Related]
39. Practical Approaches to Antipsychotic-Associated Corrected QT Interval Prolongation in Patients With Serious Mental Illness: A Review of Cases.
Cunha AL; Schwartz SE; Cooper JB
J Pharm Pract; 2023 Aug; 36(4):817-829. PubMed ID: 35325582
[No Abstract] [Full Text] [Related]
40. QTc variability in schizophrenia patients treated with antipsychotics and healthy controls.
Rettenbacher MA; Eder-Ischia U; Bader A; Edlinger M; Hofer A; Hummer M; Kemmler G; Weiss EM; Hochleitner M; Fleischhacker WW
J Clin Psychopharmacol; 2005 Jun; 25(3):206-10. PubMed ID: 15876897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
